Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models

Autor: Sebastiano Carlone, Patrizia Piccioli, Vanessa Cossu, Cecilia Marini, Patrizia Castellani, Enrica Balza, Sonia Carta, Anna Rubartelli, Gianmario Sambuceti

Publikováno v: Cancer Medicine 11 (2022): 183–193. doi:10.1002/cam4.4371
info:cnr-pdr/source/autori:Balza E.; Carlone S.; Carta S.; Piccioli P.; Cossu V.; Marini C.; Sambuceti G.; Rubartelli A.; Castellani P./titolo:Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models/doi:10.1002%2Fcam4.4371/rivista:Cancer Medicine/anno:2022/pagina_da:183/pagina_a:193/intervallo_pagine:183–193/volume:11
Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 183-193 (2022)

Triple negative breast cancers (TNBCs) are very aggressive and have a poor prognosis due to lack of efficacious therapies. The only effective treatment is chemotherapy that however is frequently hindered by the occurrence of drug resistance. We appro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa07eb61f9586f7eeb4497c5b8d886ef
https://doi.org/10.1002/cam4.4371

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.